View the ALIASSIMINI registration information details.
Back to drug list
ItemsDrug Registration information
ID1584
No1584
Brand NameALIASSIMINI
IngredientsASCIMINIB HYDROCHLORIDE 40 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size60 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsPHILADELPHIA CHROMOSOME POSITIVE MYELOID LEUKEMIA (PH+CML) IN CHRONIC PHASE, PREVIOUSLY TREATED WITH TWO OR MORE TYROSINE KINASE INHIBITOR
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionRED TABLET
Note
License OwnerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
ManufacturerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No10 L 1221/24
FDD Registration Date31/10/2024
Expiry Date30/10/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA